|
|
Article: The Smart Take on Statins; Are cholesterol-lowering drugs right for you? That depends.
- Article from:
- U.S. News & World Report
- Article date:
- February 18, 2008
- Author:
-
|
Copyright informationCOPYRIGHT 2008 All rights reserved. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Deborah Kotz
Until a few weeks ago, Larry Cohen believed he'd finally figured out how to beat his high cholesterol and stave off heart disease. Zocor, a statin that works by blocking the production of cholesterol in the liver, had brought his levels of "bad" LDL cholesterol down from a whopping 195 milligrams per deciliter to a still-disappointing 125. Next, on Vytorin, a combination of Zocor and a nonstatin drug that reduces the absorption of cholesterol in the gut, he dropped to a desirable 98 mg/dL. Then came word that Vytorin is no better at preventing plaque buildup in the arteries than Zocor. Suddenly, Cohen and millions of other people faced two big ...
Related newspaper, magazine, and journal articles:
|
|
Article: Rating your risks and taking action. (Heart Disease Handbook, part 1)
Environmental Nutrition;
February 1, 1997 ;
700+ words
......efforts to fend off heart disease may gain the...their risk of heart attack and stroke. But...of suffering a heart attack or stroke at...push to prevent heart disease should start...woman who has a heart attack is twice as likely...defense up against ...
|
|